Logo

American Heart Association

Showing 0 Abstracts.

Antihypertensive Efficacy of Angiotensin Receptor Blockers with and without Inverse Agonism: A Systematic Review and Network Meta-analysis

Liu Jing , Geng Jialu , Liu Jiakun , Hu Lei , Du Huimin , Hung Ivan Tjong A , Fang Jia

Presentation/Board Number: FR425

Hypertension 2025 Scientific Sessions

Poster Session 2 with Breakfast Reception

69

Antihypertensive Medication Prescription Patterns at Baseline in the LINKED-HEARTS Program: A Comparative Analysis with American Heart Association Guidelines

Adomako Nana Ofori , Chen Yuling , Demarco Samantha , Chepkorir Joyline , Owusu Nti Kezia , Slone Sarah , Commodore-mensah Yvonne , Himmelfarb Cheryl

Presentation/Board Number: TAC129

Hypertension 2025 Scientific Sessions

Poster Session 1 and Reception (includes TAC Poster Competition)

72

Antihypertensive Medication Timing and Cardiovascular Events and Death The BedMed Randomized Clinical Trial. irzepatide for the treatment of OSA and obesity

Voora Raven

Presentation/Board Number:

Hypertension 2025 Scientific Sessions

My Top Clinical-Practice Changing Papers this Year

67

Antioxidants

Kent Thomas

Presentation/Board Number:

International Stroke Conference 2025

Stroke in the Lab World: Investigational Targets in Ischemic Stroke: Ready, Set, Translate!

124

Antiplatelet Management for the SAH Patient with an EVD

Mclaughlin Diane

Presentation/Board Number:

International Stroke Conference 2025

Nursing Symposium: Acute Care

112

Antiplatelet therapy in chronic coronary syndromes: Less is more

Andreotti Felicita , Gorog Diana

Presentation/Board Number:

Scientific Sessions 2024

Shifting Paradigms in Chronic Coronary Syndromes: What We Thought We Knew (AHA Joint Session with European Society of Cardiology Society)

117

Antiplatelet Use for Primary Prevention

Simpkins Alexis , Chaturvedi Seemant

Presentation/Board Number:

Scientific Sessions 2024

Primary Prevention of Stroke

134

Antisense Oligonucleotide Treatment of Calmodulinopathy

Bortolin Raul , Yoshinaga Daisuke , Pavlaki Nikoleta , Cavazzoni Cecilia B. , T. Sage Peter , D. Whitehill Robert , Abrams Dominic , Carreon Chrystalle , Putra Juan , Alexandrescu Sanda , Guo Shuai , Nawar Farina , Tsai Owen , Rubart Michael , Kubli Dieter , Mullick Adam , Bezzerides Vassilios , Pu William , Trembley Michael , Prondzynski Maksymilian , Sweat Mason , Wang Peizhe , Chaehyoung Park , Lu Fujian , Keating Erin

Presentation/Board Number: We099

Basic Cardiovascular Sciences

Poster Session and Reception 3

180

Antithrombotic prophylaxis in patients with peripheral arterial disease

Bonaca Marc , Creager Mark

Presentation/Board Number:

Scientific Sessions 2024

Team Science Approaches for Vascular Disease Research - AHA SFRN, Sarnoff Foundation, and Leducq Foundation

136

Antithrombotic Strategies and Outcomes in Neonates and Infants with Cardiac Shunts: A Systematic Review and Meta-analysis

Kiskaddon Amy , Do Nhue , Goldenberg Neil , Betensky Marisol , Branstetter Joshua , Ashour Dina , Williams Pamela , Stock Arabela , Silvey Michael , Giglia Therese

Presentation/Board Number: Sa3028

Scientific Sessions 2025

Epidemiology and Prognotic Tools in Pediatric and Congenital Heart Care

33

Antithrombotic Strategies for Stroke Prevention in Elderly Patients with Atrial Fibrillation: A Meta-Analysis of Contemporary Evidence

Farooq Talha , Pandit Maleeha , Ali Mohammad Eisa , Ahsan Muhammad , Khan Abdul Moiz , Qasim Muhammad , Qayyum Mahhum , Akram Anusha , Kamel Mohammed , Naseem Ali

Presentation/Board Number: MP1201

Scientific Sessions 2025

Stroke Risk, Reperfusion, and Disparities: Insights from Data and Trials

30

Antithrombotic Strategy and Long-term Outcome In dialysis patients with coexisting acute coronary syndrome and atrial fibrillation: a nationwide study

An Shuoyan , Zhao Xuecheng , Li Jiahui , Zheng Jingang

Presentation/Board Number: Sa1036

Scientific Sessions 2025

Extending the Reach: Epidemiology and Therapeutic Innovation in Cardiovascular Care for Late-Stage CKD

32